We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
-18.63%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.03B
AUM Growth
-$689M
(-25%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-5.7%
Top 10 Holdings %
Top 10 Hldgs %
20.08%
Holding
282
New
27
Increased
73
Reduced
123
Closed
38
Top Buys
| 1 |
Green Dot
GDOT
|
+$23.4M |
| 2 |
Churchill Downs
CHDN
|
+$20.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$18.4M |
| 4 |
Insperity
NSP
|
+$16.1M |
| 5 |
Teladoc Health
TDOC
|
+$14.2M |
Top Sells
| 1 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$25.4M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$23.8M |
| 3 |
FCB
FCB Financial Holdings, Inc.
FCB
|
+$23.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$23.6M |
| 5 |
KYNB
Kyntra Bio
KYNB
|
+$19.2M |
Sector Composition
| 1 | Healthcare | 19.19% |
| 2 | Technology | 18.37% |
| 3 | Consumer Discretionary | 18.29% |
| 4 | Industrials | 14.17% |
| 5 | Financials | 9.61% |
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, Emerald Advisers held 282 positions worth $2.03B, down 25% from $2.72B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Emerald Advisers withdrew a net $116M in Q4 2018, closing 38 positions and reducing 123 holdings. Its most notable exit was G1 Therapeutics, Inc. Common Stock, an estimated $25.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Emerald Advisers opened a new position in Green Dot worth $23.6M.
- Emerald Advisers's largest Q4 2018 buy was Green Dot: 296,199 shares worth $23.6M.
- Emerald Advisers added most to Teladoc Health in Q4 2018, an estimated $14.2M increase.
- Emerald Advisers's biggest Q4 2018 reduction was Kennametal, cutting an estimated $18.3M.
- Emerald Advisers fully exited G1 Therapeutics, Inc. Common Stock in Q4 2018, selling an estimated $25.4M.
- Emerald Advisers's ten largest holdings make up 20% of its $2.03B portfolio in Q4 2018.
- Emerald Advisers opened 27 new positions and closed 38 in Q4 2018.
- Emerald Advisers's portfolio value fell 25% quarter-over-quarter to $2.03B.
Based on Emerald Advisers's 13F filing for Q4 2018, filed 30 Jan 2019.